ClinicalTrials.Veeva

Menu

Observational Study to Evaluate the Influence of Undercast Material Types on Skin Microbiome (Microbiome II)

B

BSN Medical

Status

Completed

Conditions

Skin Microbiome
Undercast Materials

Treatments

Device: water resistante padding
Device: non water resistante padding

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This clinical study will evaluate the clinical performance and the safety of the CE-marked casting and padding materials when used in routine fracture care without any additional invasive methods and within the intended use. As primary objective the cast therapy´s influence on skin microbiome during fracture management will be investigated. Further, the influence of the padding material on the skin microbiome, device comfort, skin conditions, and impact on daily life activities as well as HCP´s and patient´s satisfaction and general product safety and performance are considered as secondary outcomes.

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject ≥ 18 years of age
  2. Patient is physically and mentally able to participate in this study
  3. Proper understanding of the Dutch language
  4. Signed informed consent
  5. Fractures to be treated with a short-arm cast without thumb inclusion for the period of 3 weeks (e.g. 2R3A1 = radial styloid avulsion, 2R3A2 = Simple radial fracture, 2U3A1 = Ulnar fracture of the base of the styloid process, 2U3A2= Simple distal ulna fracture, 2R3B1 = Intraarticular fracture of the styloid process of the radius (not displaced) or Triquetrum fracture (non AO classified))

Exclusion criteria

  1. Subject <18 years of age
  2. Pregnancy, breast feeding
  3. Participation in other clinical trials
  4. Patient is neither physically nor mentally able to participate in this study
  5. Non-intact skin in treatment area (including dermatological issues)
  6. Patients with impaired (e.g. Cortisone skin, extremely dry skin, parchment skin) or damaged skin with either a surgical wound or a traumatic wound
  7. Medical treatment prior casting which could influence the microbiome
  8. Known Blood Circulatory Diseases
  9. Known Lymphedema or any general disorder of the lymphatic system
  10. Known Osteoporosis
  11. Known Diabetes
  12. Knowing of one of the following illnesses that might require regular systemic medication: cancer, rheumatic disease
  13. Intolerability or documented allergies against cast materials
  14. Subjects with not "normal" (unusual) hygienic behavior
  15. Suspected drug addiction or alcohol abuse
  16. Patients diagnosed HIV-positive or with infectious hepatitis based on self-declaration by subjects

Trial design

108 participants in 2 patient groups

Test group
Description:
will receive water resistante padding and a cast
Treatment:
Device: water resistante padding
Control group
Description:
will receive traditional non-water resistante padding and cast
Treatment:
Device: non water resistante padding

Trial contacts and locations

3

Loading...

Central trial contact

Hardy Schweigel, Dr.; Laura Ruschkies, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems